Skip to main content

Multiplex Detection: From Discovery to Clinical Practice

Keith Wharton, MD PhD FCAP

Learning Objectives

  • Monoplex vs Multiplex staining
  • Multiplexing in research including biopharma and drug development
  • Pathways to clinical implementation

Leica Biosystems content is subject to the Leica Biosystems website terms of use, available at: Legal Notice. The content, including webinars, training presentations and related materials is intended to provide general information regarding particular subjects of interest to health care professionals and is not intended to be, and should not be construed as, medical, regulatory or legal advice. The views and opinions expressed in any third-party content reflect the personal views and opinions of the speaker(s)/author(s) and do not necessarily represent or reflect the views or opinions of Leica Biosystems, its employees or agents. Any links contained in the content which provides access to third party resources or content is provided for convenience only.

For the use of any product, the applicable product documentation, including information guides, inserts and operation manuals should be consulted.

Copyright © 2024 Leica Biosystems division of Leica Microsystems, Inc. and its Leica Biosystems affiliates. All rights reserved. LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.

About the presenter

Keith Wharton, MD PhD FCAP

Keith Wharton has 30+ years of experience in academic and biopharma settings, including Leica Biosystems, Novartis, and Biogen. Following board certification in anatomic pathology and fellowship training in autopsy pathology and developmental biology at Stanford University, he ran an NIH-funded research laboratory at UT Southwestern Medical Center and held several leadership positions including Pathology course director, Director of the Laboratory of Molecular Pathology, and Associate Dean.